Metraipolis › archive › dc_34852bc7c664

Transition Into Clinical Routine and Survival Outcomes of BCL2- and BTK Inhibitors: An Analysis of Patient Data From the GCLLSG Registry — Europe PMC PMID:41978941

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41978941
DOI
10.1111/ejh.70178
License (as archived)
solo-consultazione
Archived
2026-10-08T04:50:52.771Z
SHA-256 of the archived text
e536a9e9f6f0c1fd217d07a3d92b01681cedb5ed0655d4e959b920b0a856e7d2
Stable URL of this page
https://metraipolis.com/documento/dc_34852bc7c664

How to cite

Transition Into Clinical Routine and Survival Outcomes of BCL2- and BTK Inhibitors: An Analysis of Patient Data From the GCLLSG Registry — Europe PMC PMID:41978941 — Europe PMC (en), https://europepmc.org/article/MED/41978941 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_34852bc7c664 (Metraipolis archive dc_34852bc7c664, sha256 e536a9e9f6f0c1fd217d07a3d92b01681cedb5ed0655d4e959b920b0a856e7d2)
BibTeX
@misc{dc34852bc7c664,
  title = {Transition Into Clinical Routine and Survival Outcomes of BCL2- and BTK Inhibitors: An Analysis of Patient Data From the GCLLSG Registry — Europe PMC PMID:41978941},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41978941},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_34852bc7c664; sha256 e536a9e9f6f0c1fd217d07a3d92b01681cedb5ed0655d4e959b920b0a856e7d2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41978941. Agents can read the archived copy with the MCP tool read_document.